Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat
暂无分享,去创建一个
F. Westwood | I. Wilson | E. Lenz | J. Bright | I D Wilson | H. Major | E M Lenz | J Bright | R Knight | F R Westwood | D Davies | H Major | R. Knight | D. Davies
[1] Ina Schuppe-Koistinen,et al. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. , 2003, Analytical chemistry.
[2] I. Wilson,et al. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. , 2004, The Analyst.
[3] E Holmes,et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.
[4] J C Lindon,et al. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. , 1994, Molecular pharmacology.
[5] M. Reily,et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Henrik Antti,et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.
[7] I. Wilson,et al. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. , 2004, Journal of pharmaceutical and biomedical analysis.
[8] I. Wilson,et al. Use of Proton NMR for Determining Changes in Metabolite Excretion Profiles Induced by Dietary Changes in the Rat , 1997 .
[9] I. Wilson,et al. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.
[10] J. Nicholson,et al. Investigations into the biochemical effects of region-specific nephrotoxins. , 1989, Molecular pharmacology.
[11] E Holmes,et al. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. , 2001, Chemical research in toxicology.
[12] P. Whiting,et al. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity. , 1996, Renal failure.
[13] R. Williams,et al. Effect of intestinal microflora on the urinary metabolic profile of rats: a 1 H-nuclear magnetic resonance spectroscopy study , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[14] E Holmes,et al. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. , 2002, The Analyst.
[15] Christophe Junot,et al. Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. , 2003, Rapid communications in mass spectrometry : RCM.
[16] Ian D Wilson,et al. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. , 2003, The Analyst.
[17] Robert S Plumb,et al. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. , 2002, Rapid communications in mass spectrometry : RCM.
[18] I. Wilson,et al. Nuclear magnetic resonance and high-performance liquid chromatography-nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide. , 1996, Therapeutic drug monitoring.